METHYLPHENIDATE HYDROCHLORIDE
METHYLPHENIDATE HYDROCHLORIDE
Approval overview METHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 210354 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPHENIDATE HYDROCHLORIDE Form and strength TABLET, CHEWABLE;ORAL - 2.5MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-10-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 210354 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPHENIDATE HYDROCHLORIDE Form and strength TABLET, CHEWABLE;ORAL - 2.5MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-10-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.